Summit Trail Advisors LLC Buys Shares of 473 Axon Enterprise, Inc. (NASDAQ:AXON)

Summit Trail Advisors LLC purchased a new position in Axon Enterprise, Inc. (NASDAQ:AXON) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 473 shares of the biotechnology company’s stock, valued at approximately $281,000.

Several other institutional investors and hedge funds have also modified their holdings of the business. FSR Wealth Management Ltd. bought a new position in Axon Enterprise in the 4th quarter worth $238,000. Comprehensive Financial Planning Inc. PA purchased a new stake in Axon Enterprise in the fourth quarter worth about $150,000. Savant Capital LLC raised its stake in shares of Axon Enterprise by 5.7% in the fourth quarter. Savant Capital LLC now owns 1,080 shares of the biotechnology company’s stock worth $642,000 after buying an additional 58 shares during the period. Burns Matteson Capital Management LLC lifted its position in shares of Axon Enterprise by 3.4% during the 4th quarter. Burns Matteson Capital Management LLC now owns 757 shares of the biotechnology company’s stock valued at $450,000 after buying an additional 25 shares in the last quarter. Finally, Kestra Private Wealth Services LLC grew its stake in shares of Axon Enterprise by 44.6% during the 4th quarter. Kestra Private Wealth Services LLC now owns 14,420 shares of the biotechnology company’s stock valued at $8,570,000 after acquiring an additional 4,449 shares during the period. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Performance

NASDAQ:AXON opened at $665.08 on Thursday. The company has a market cap of $50.71 billion, a price-to-earnings ratio of 171.86, a PEG ratio of 6.79 and a beta of 1.05. Axon Enterprise, Inc. has a 1 year low of $255.68 and a 1 year high of $698.67. The stock’s 50 day simple moving average is $623.80 and its two-hundred day simple moving average is $502.57. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63.

Insider Activity at Axon Enterprise

In related news, Director Julie A. Cullivan sold 1,261 shares of Axon Enterprise stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total value of $860,077.66. Following the completion of the transaction, the director now owns 2,392 shares in the company, valued at approximately $1,631,487.52. This trade represents a 34.52 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Jeffrey C. Kunins sold 2,304 shares of the company’s stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $654.79, for a total value of $1,508,636.16. Following the sale, the insider now owns 128,542 shares in the company, valued at approximately $84,168,016.18. This trade represents a 1.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 8,711 shares of company stock valued at $5,631,561. 6.10% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research firms have commented on AXON. JMP Securities raised their target price on shares of Axon Enterprise from $610.00 to $725.00 and gave the stock a “market outperform” rating in a research note on Tuesday, February 4th. TD Cowen initiated coverage on shares of Axon Enterprise in a research report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price objective on the stock. Northland Securities upped their target price on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a report on Monday, November 11th. Needham & Company LLC raised their price target on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a report on Friday, November 8th. Finally, Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their price objective for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. One equities research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. Based on data from MarketBeat, Axon Enterprise currently has an average rating of “Moderate Buy” and an average target price of $542.15.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.